What are strategic considerations for IPR in U.S. pharmaceutical and biotechnology fields?

A filing procedure, called Inter Partes Review(IPR), conducted to review the patentability in a technology patent registered in the U.S. pharmaceutical and biotechnology market, is conducted by a law body of the U.S. Patent and Trademark Office(USPTO) for the review.

The USPTO is an agency in the U.S. Department of Commerce, and the IPR is legislated for anyone to make a claim under the patent...